Skye Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SKYE and other ETFs, options, and stocks.

About SKYE

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. 

CEO
Punit S. Dhillon
CEOPunit S. Dhillon
Employees
12
Employees12
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2011
Founded2011
Employees
12
Employees12

SKYE Key Statistics

Market cap
25.13M
Market cap25.13M
Price-Earnings ratio
-0.53
Price-Earnings ratio-0.53
Dividend yield
Dividend yield
Average volume
176.75K
Average volume176.75K
High today
High today
Low today
Low today
Open price
$0.794
Open price$0.794
Volume
0.00
Volume0.00
52 Week high
$5.75
52 Week high$5.75
52 Week low
$0.5655
52 Week low$0.5655

Stock Snapshot

As of today, Skye Bioscience(SKYE) shares are valued at $0.73. The company's market cap stands at 25.13M, with a P/E ratio of -0.53.

Skye Bioscience(SKYE) stock opened on 2026-04-17 at $0.79. The price climbed to — and dipped to —.

The Skye Bioscience(SKYE)'s current trading volume is 0, compared to an average daily volume of 176.75K.

During the past year, Skye Bioscience(SKYE) stock moved between $0.57 at its lowest and $5.75 at its peak.

During the past year, Skye Bioscience(SKYE) stock moved between $0.57 at its lowest and $5.75 at its peak.

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own SKYE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.